SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

24 Jul 2024 Evaluate
A decent increase of about 43.16% in the sales to Rs. 6512.00 millions was observed for the quarter ended June 2024. The sales figure stood at Rs. 4548.90 millions during the year-ago period.The Net Profit of the company vaulted to 171.50% to Rs. 860.10  millions from Rs. 316.80 millions in the previous quarter.Operating profit surged to 1788.00 millions from the corresponding previous quarter of 967.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 6512.00 4548.90 43.16 6512.00 4548.90 43.16 19291.92 21884.00 -11.84
Other Income 24.00 15.20 57.89 24.00 15.20 57.89 65.15 79.84 -18.40
PBIDT 1788.00 967.10 84.88 1788.00 967.10 84.88 4877.26 6969.81 -30.02
Interest 142.50 183.30 -22.26 142.50 183.30 -22.26 734.89 655.02 12.19
PBDT 1645.50 783.80 109.94 1645.50 783.80 109.94 4142.37 6314.79 -34.40
Depreciation 334.50 308.00 8.60 334.50 308.00 8.60 1235.64 1089.53 13.41
PBT 1311.00 475.80 175.54 1311.00 475.80 175.54 2906.73 5225.26 -44.37
TAX 450.90 159.00 183.58 450.90 159.00 183.58 948.84 1691.69 -43.91
Deferred Tax 219.20 70.50 210.92 219.20 70.50 210.92 421.74 748.61 -43.66
PAT 860.10 316.80 171.50 860.10 316.80 171.50 1957.89 3533.57 -44.59
Equity 415.50 415.50 0.00 415.50 415.50 0.00 415.50 415.50 0.00
PBIDTM(%) 27.46 21.26 29.15 27.46 21.26 29.15 25.28 31.85 -20.62

Epigral Share Price

1300.65 -26.90 (-2.03%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3865.25
Tata Chemicals 761.95
SRF 2798.45
Pidilite Inds. 1436.40
Deepak Nitrite 1861.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×